EC Healthcare Stock: price and insider trades · Hong Kong
3 insiders bought €252k of shares over the last 90 days, the latest by Lu Lyn Wade Leslie, filed 30 Oct 2026.
Cluster: 2 buyers in 30 daysEC Healthcare: what insiders have been doing
Every trade that managers of EC Healthcare disclose to HKEX is tracked on this page. The company sits in the Health Care sector. Over the twelve months to 8 November 2026, 16 filings were filed, from 3 insiders.
Not one open-market sale was filed. On the buying side, 3 insiders reported 16 purchases totalling €252k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. On the buying side, the filings list 3 senior executives among the declarants. Biggest ticket of the year: €86k, bought by TANG Chi Fai and made public on 15 September 2026.
For context, the typical company on the same exchange (median of 1,323 companies) published 4 filings over the same period, against 16 filings here. Over the whole record (from 2017), the tally stands at 74 purchases and 12 sales.
Within a 30-day window, 15 purchases overlapped with buying by a second insider. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The clock since the last published purchase (30 October 2026) now reads 10 days. Between a trade and the moment it shows up on HKEX, the median delay is 3 days. That lag is the time during which only the insider knows about the trade.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. Source: insider filings from HKEX. Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- -9.6%Entry HK$0.57 · Close 06 Nov 2026 HK$0.52
- -4.6%Entry HK$0.55 · Close 06 Nov 2026 HK$0.52
- -36.4%Entry HK$7.59 · Close at T+365 HK$4.83
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 73,000 shares@ HK$0.51720.0059% mcap81.4% of flowShareXHKGHKEX:DA20261030E00212Canonical exit: 25 Jan 2027 (T+90)
- 17,000 shares@ HK$0.510.0014% mcap100.0% of flowShareXHKGHKEX:DA20261025E00001Canonical exit: 20 Jan 2027 (T+90)
- 145,000 shares@ HK$0.51340.012% mcap2.8% of flowShareXHKGHKEX:DA20261022E00579Canonical exit: 18 Jan 2027 (T+90)
- 194,000 shares@ HK$0.60950.017% mcap10.2% of flowShareXHKGHKEX:DA20261002E00153Canonical exit: 29 Dec 2026 (T+90)
- 200,000 shares@ HK$0.56370.017% mcap10.8% of flowShareXHKGHKEX:DA20260928E00359Canonical exit: 24 Dec 2026 (T+90)
- 84,000 shares@ HK$0.56440.0072% mcap5.1% of flowShareXHKGHKEX:DA20260925E00415Canonical exit: 23 Dec 2026 (T+90)
- 268,000 shares@ HK$0.53870.024% mcap12.3% of flowShareXHKGHKEX:DA20260924E00618Canonical exit: 22 Dec 2026 (T+90)
- 139,000 shares@ HK$0.51820.012% mcap6.1% of flowShareXHKGHKEX:DA20260922E00517Canonical exit: 21 Dec 2026 (T+90)
- 335,000 shares@ HK$0.5017.2% of flowShareXHKGHKEX:DA20260918E00735Canonical exit: 15 Dec 2026 (T+90)
- 335,000 shares@ HK$0.5017.2% of flowShareXHKGHKEX:DA20260918E00736Canonical exit: 15 Dec 2026 (T+90)
- 94,000 shares@ HK$0.5155.4% of flowShareXHKGHKEX:DA20260918E00004Canonical exit: 16 Dec 2026 (T+90)
- 200,000 shares@ HK$0.502511.2% of flowShareXHKGHKEX:DA20260918E00002Canonical exit: 15 Dec 2026 (T+90)
- 50,000 shares@ HK$0.502.6% of flowShareXHKGHKEX:DA20260915E00634Canonical exit: 14 Dec 2026 (T+90)
- 50,000 shares@ HK$0.502.6% of flowShareXHKGHKEX:DA20260915E00635Canonical exit: 14 Dec 2026 (T+90)
- 700,000 shares@ HK$0.509639.5% of flowShareXHKGHKEX:DA20260915E00605Canonical exit: 13 Dec 2026 (T+90)
- 200,000 shares@ HK$0.50511.2% of flowShareXHKGHKEX:DA20260916E00004Canonical exit: 14 Dec 2026 (T+90)
- 157,000 shares@ HK$0.4898.5% of flowShareXHKGHKEX:DA20260915E00142Canonical exit: 10 Dec 2026 (T+90)
- 1,571,000 shares@ HK$0.499480.2% of flowShareXHKGHKEX:DA20260915E00205Canonical exit: 10 Dec 2026 (T+90)
- 1,571,000 shares@ HK$0.499480.2% of flowShareXHKGHKEX:DA20260915E00212Canonical exit: 10 Dec 2026 (T+90)
- 7,683,000 sharesShareXHKGHKEX:DA20250102E00006
- 170,000 shares@ HK$5.02820.8% of flowShareXHKGHKEX:DA20220908E00154Canonical exit: 6 Dec 2022 (T+90)
- 107,000 shares@ HK$5.49050.5% of flowShareXHKGHKEX:DA20220901E00785Canonical exit: 30 Nov 2022 (T+90)
- 50,000 shares@ HK$8.5024.1% of flowShareXHKGHKEX:DA20220615E00363Canonical exit: 22 May 2022 (T+90)
- 1,000,000 shares@ HK$7.24656.1% of flowShareXHKGHKEX:DA20220308E00412Canonical exit: 5 Jun 2022 (T+90)
- 543,000 shares@ HK$8.1773.6% of flowShareXHKGHKEX:DA20220224E00240Canonical exit: 23 May 2022 (T+90)
25 of 104 declarations
About EC Healthcare
EC Healthcare is a company focused on healthcare services, providing innovative solutions to enhance patient well-being. It emphasizes the integration of technology in healthcare to optimize service efficiency.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
